In vitro activities of arylomycin natural-product antibiotics against Staphylococcus epidermidis and other coagulase-negative staphylococci
about
Imaging mass spectrometry and genome mining via short sequence tagging identified the anti-infective agent arylomycin in Streptomyces roseosporusA putative cro-like repressor contributes to arylomycin resistance in Staphylococcus aureus.Origins of Yersinia pestis sensitivity to the arylomycin antibiotics and the inhibition of type I signal peptidaseSecA: a potential antimicrobial target.Type I signal peptidase and protein secretion in Staphylococcus aureus.An Alternative Terminal Step of the General Secretory Pathway in Staphylococcus aureus.Broadening the spectrum of β-lactam antibiotics through inhibition of signal peptidase type I.The inhibition of type I bacterial signal peptidase: Biological consequences and therapeutic potential.Mechanism of action of the arylomycin antibiotics and effects of signal peptidase I inhibitionA Putative Bacterial ABC Transporter Circumvents the Essentiality of Signal Peptidase.Efforts toward broadening the spectrum of arylomycin antibiotic activity.Signal peptidase I: cleaving the way to mature proteins.Bacterial type I signal peptidases as antibiotic targets.Strained cyclophane natural products: macrocyclization at its limits.Harnessing the power of transposon mutagenesis for antibacterial target identification and evaluation.
P2860
Q31038560-D500F139-C367-41F4-A3E8-4A6223A49E0BQ35607659-84FACF0B-32DD-4E45-9621-83125FF31217Q35746200-0A6233EF-B512-4266-86B2-2835D71D4A3FQ35777207-8EF23DFB-0B9A-49AB-B0A2-305939CEF641Q35943131-F4DEA691-97AD-4273-B1D8-137F488EFC9FQ35973012-3115BBD9-18BD-4539-A3F6-AD58D7B01B51Q36172566-2A80EE9A-DD64-4D25-AFC1-C8242840D49CQ36208442-60170336-25F9-4916-A719-8956DDB37C05Q36276904-B213E6A3-1C8B-487F-B9EE-D2895DA627CDQ37236298-C9E7751D-8C57-4239-96C2-8D297E8721F2Q37694493-304E1C7F-1B09-4B50-9FD4-6FDE8F67FE08Q37949867-7B2EE6FC-0888-418A-80B8-21B07D86E568Q37955948-9463B9E7-312C-46D9-A6DC-AAD423032EB7Q38021350-01DF2DE6-63F8-4ABC-BE7C-C397905EA214Q39531375-FD0DC5EA-56A4-43AD-95C0-C1B740449CB8
P2860
In vitro activities of arylomycin natural-product antibiotics against Staphylococcus epidermidis and other coagulase-negative staphylococci
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
In vitro activities of arylomy ...... agulase-negative staphylococci
@ast
In vitro activities of arylomy ...... agulase-negative staphylococci
@en
In vitro activities of arylomy ...... agulase-negative staphylococci
@nl
type
label
In vitro activities of arylomy ...... agulase-negative staphylococci
@ast
In vitro activities of arylomy ...... agulase-negative staphylococci
@en
In vitro activities of arylomy ...... agulase-negative staphylococci
@nl
prefLabel
In vitro activities of arylomy ...... agulase-negative staphylococci
@ast
In vitro activities of arylomy ...... agulase-negative staphylococci
@en
In vitro activities of arylomy ...... agulase-negative staphylococci
@nl
P2093
P2860
P356
P1476
In vitro activities of arylomy ...... agulase-negative staphylococci
@en
P2093
Floyd E Romesberg
Michael E Powers
Peter A Smith
P2860
P304
P356
10.1128/AAC.01459-10
P407
P577
2010-12-28T00:00:00Z